Research programme: human monoclonal antibodies - Genmab/deCODE
Alternative Names: Human monoclonal antibodies research programme - Genmab/deCODELatest Information Update: 15 Sep 2006
At a glance
- Originator deCODE genetics; Genmab
- Developer deCODE genetics; Genmab; Medarex
- Class Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Cardiovascular disorders; Inflammation
Most Recent Events
- 03 Feb 2003 This programme is still in active development
- 18 Jul 2001 Preclinical development for Cardiovascular disorders in Denmark (Unknown route)
- 18 Jul 2001 Preclinical development for Cardiovascular disorders in Iceland (Unknown route)